About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials in Atlanta | 34 Studies

Clinical Trials DiabetesAtlanta

Diabetes Clinical Trials in Atlanta

Find 34 clinical trials for diabetes near Atlanta, Georgia. Connect with research centers in your area.

All Diabetes trials nationwide All trials in Atlanta

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 34 trials

CompletedClosed Loop Glucose Control in Patients With Type 1 and Type 2 DiabetesThis is a proof of concept safety study of an artificial intelligence based closed loop glucose control system designed for use in the intensive care unit setting.NCT05644730·Atlanta, Georgia CompletedSafety of Inhaled Insulin With Type 1 and Type 2 DiabetesPulmonary Safety in Diabetics with T/INCT00308737·Phoenix, Arizona and 175 others

Diabetes Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedAutomated Insulin Delivery for Inpatients With DysglycemiaThis randomized controlled trial will test the efficacy and safety of automated insulin delivery (AID) in hospitalized patients with diabetes (type 1 or type 2) requiring insulin…NCT06418880·Stanford, California and 2 others

CompletedEffectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring SystemsThe purpose of the study is to evaluate the safety and effectiveness of the Abbott Sensor Based Glucose Monitoring System Personal (System-P) and Abbott Sensor Based Glucose…NCT02283411·Santa Barbara, California and 5 others

CompletedEfficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesThe purpose of this study is to evaluate the safety and effectiveness of alogliptin combined with metformin, once daily (QD) or twice daily (BID), in participants with Type 2…NCT01023581·Dothan, Alabama and 200 others

CompletedAfrezza® INHALE-1 Study in PediatricsINHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the Afrezza group) versus…NCT04974528·Los Angeles, California and 38 others

CompletedEvaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring SystemThe purpose of this study is to demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring (GM) System interstitial glucose results against Reader capillary Blood…NCT02073058·Escondido, California and 3 others

Active not recruitingEversense® Non-adjunctive Use Post Approval StudyThis is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effectiveness of diabetes with the…NCT04836546·Los Angeles, California and 22 others

Active not recruitingGATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesThe purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disposable Sensor 5/Simplera Sync…NCT07228117·Little Rock, Arkansas and 32 others

CompletedPost Approval Study of the Eversense® Continuous Glucose MonitoringA Post Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System over repeat insertion and removal cycles and…NCT03908125·Newport Beach, California and 16 others

WithdrawnSafety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient SurgeryThe purpose of this study is to compare the safety and efficacy of intravenous (IV) administration of FDA approved regular human insulin and subcutaneous (SC) administration of…NCT01971047·Atlanta, Georgia

CompletedFeasibility Study of New Subcutaneous Glucose Sensor With Recording DevicesThe purpose of Phase 3 Group is to evaluate the impact of acetaminophen on the performance of Guardian Sensor (3) during 11 days of wear (approximately 264 hours) in subjects with…NCT04020822·Aurora, Colorado and 1 other

TerminatedPulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166The purpose of this study is to evaluate pulmonary function test (PFT) sub-study in interested subjects from studies MKC-TI-161, MKC-TI-162 and MKC-TI-166.NCT01201928·Fresno, California and 13 others

CompletedAdult Accuracy Study of the Enlite 3 Glucose SensorThe purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and…NCT02246582·Escondido, California and 5 others

CompletedTreatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesThe purpose of this protocol is to determine if an investigational drug is effective in treating nerve malfunction in diabetes.NCT00044395·Mesa, Arizona and 38 others

TerminatedEfficacy of Aliskiren in the Treatment of Diabetic Macular EdemaTo assess the efficacy of oral aliskiren as a therapy for diabetic macular edemaNCT00768040·Phoenix, Arizona and 11 others

RecruitingModeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of GlucotoxicityThe goal of this study is to quantify day-to-day changes in blood glucose during treatment towards remission in ketosis-prone diabetes (KPDM) and describe them using a…NCT06699810·Atlanta, Georgia and 1 other

TerminatedA Study in Participants With Diabetic Kidney DiseaseThe purpose of this study is to determine if LY2382770 is safe and effective at protecting kidney function in participants with kidney disease due to diabetes.NCT01113801·Phoenix, Arizona and 77 others

CompletedPROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 DaysThe purpose of this clinical investigation is to evaluate the accuracy of the Eversense® continuous Glucose Monitoring System (Eversense® 180 CGM System) measurements when…NCT03808376·Concord, California and 7 others

TerminatedInhaled Technosphere Insulin in Subjects With Diabetes Mellitus and AsthmaThe clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes…NCT00332826·Phoenix, Arizona and 77 others

Page 1 of 2Next

Other Conditions in Atlanta

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia